InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
20%
T+90 mean return
+17.3%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Feingold Jay, Directeur Médical. Officer active across 1 company, notably Pyxis Oncology, Inc.. Aggregated, 5 disclosures have been logged. History available since 7 October 2021. The latest transaction was disclosed on 24 March 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
209,803 shares0Common StockSEC:0001209191-23-021412:0
53,931 shares0Common StockSEC:0001567619-23-000067:0
115,931 shares0Common StockSEC:0001567619-22-008614:0
306,930 shares0Common StockSEC:0001140361-22-012918:0
43,750 shares0Common StockSEC:0001140361-21-034424:0
5 of 5 declarations
About Feingold Jay
Jay Feingold is the Chief Medical Officer of Pyxis Oncology, Inc. He oversees the medical and clinical aspects of the company, ensuring compliance with health standards.
